Navigation Links
Cadence Pharmaceuticals' CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
Date:10/28/2009

SAN DIEGO, Oct. 28 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Ted Schroeder will present the company's corporate overview on Wednesday, November 4, 2009 at 2:45pm Eastern Time (11:45am Pacific Time) during the Oppenheimer 20th Annual Healthcare Conference at the Waldorf Astoria Hotel in New York City.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 90 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company is currently developing Acetavance(TM) (intravenous acetaminophen), its investigational product candidate for the treatment of acute pain and fever. For more information about Cadence's pipeline, visit www.cadencepharm.com.

Cadence(TM) and Acetavance(TM) are trademarks of Cadence Pharmaceuticals, Inc.

    Contacts:   William R. LaRue
                SVP, CFO
                Cadence Pharmaceuticals, Inc.
                858-436-1400

SOURCE Cadence Pharmaceuticals, Inc.


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
6. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
7. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
9. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 2014 Just days before the government of ... contain the spread of Ebola, World Vision will begin a ... thanks to private donations. McKesson, the largest healthcare ... through its affiliate McKesson Medical-Surgical donated four million pairs of ... Sierra Leone,s needs for the next ...
(Date:9/18/2014)... CHESTERBROOK, Pa. , Sept. 18, 2014 ... Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ) ... has approved a supplemental new drug application (sNDA) for STENDRA ... dysfunction (ED) medication indicated to be taken as early as ... a prescription medication in a class of drugs known as ...
(Date:9/17/2014)... , Sept. 17, 2014 /PRNewswire-iReach/ -- DeepResearchReports.com ... Methacrylate (MMA) Industry" and "2014 Market Research Report ... reports to its store. Photo - ... Research Report on Global Methyl Methacrylate (MMA) Industry" ... China and Global Methyl ...
Breaking Medicine Technology:World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 2World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 3World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 4VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 2VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 3VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 4VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 5VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 6VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 7VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 8VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 9Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 2Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 3Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 4Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 5
... , EMERYVILLE, Calif.,Oct. 29 Bionovo, Inc. (Nasdaq: BNVI ... the third quarter of fiscal year 2009 ended September 30, ... a conference call and web cast to review the financial ... , Interested parties can access the call by dialing (800) ...
... Ferring Pharmaceuticals Inc. announces the appointment of Harry ... Dr. Kovelman will be responsible for medical affairs ... knee pain due to osteoarthritis, as well as Ferring,s ... exceptionally well qualified to fill this role," said Edward ...
Cached Medicine Technology:Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics 2Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics 3
(Date:9/18/2014)... (PRWEB) September 18, 2014 Results from ... been released and it reveals that pornography is an ... also harms marriages. The findings are based upon a ... and conducted by Barna Group among a nationally representative ... included numerous questions focusing upon the frequency of use ...
(Date:9/18/2014)... HealthDay Reporter WEDNESDAY, Sept. ... be associated with increased odds of developing Parkinson,s disease ... suggests. The study, which did not prove a ... that the migraine-Parkinson,s association was stronger in women with ... sign of a pending attack that includes flashes of ...
(Date:9/18/2014)... September 18, 2014 A positive outlook on ... improve your health. This year, at the Weekend for Women ... that adored LA radio talk show host Mother Love will ... with diabetes. , The always-funny Jo Anne Hart, aka ... best known for her widely acclaimed talk show on LATalkRadio.com, ...
(Date:9/18/2014)... 18, 2014 Altec Products, Inc., a ... today that it will partake in the fifth annual ... States and more than three weeks will provide attendees ... Microsoft Dynamics® GP and SL solutions. , McGladrey is ... focused on the middle market. McGladrey strives to help ...
(Date:9/18/2014)... Texas Physical Therapy Specialists (TexPTS) is proud ... Physicians Association (HPA) Friends and Family Golf tournament ... The tournament, which will take place at TopGolf from ... scholarships through three golf challenges, “Top Scramble”, “Top Score”, ... is provided at the event and there will be ...
Breaking Medicine News(10 mins):Health News:2014 Study shows that pornography is an addiction that risks employment and harms marriages 2Health News:2014 Study shows that pornography is an addiction that risks employment and harms marriages 3Health News:2014 Study shows that pornography is an addiction that risks employment and harms marriages 4Health News:2014 Study shows that pornography is an addiction that risks employment and harms marriages 5Health News:Are Migraines in Middle Age Tied to Raised Parkinson's Risk Later? 2Health News:Are Migraines in Middle Age Tied to Raised Parkinson's Risk Later? 3Health News:DiabetesSisters Showcases Radio Talk Show Host Mother Love at Weekend for Women Conference in Los Angeles 2Health News:Altec Announces Participation in Fifth Annual McGladrey Dynamics Summit 2Health News:Altec Announces Participation in Fifth Annual McGladrey Dynamics Summit 3Health News:Texas Physical Therapy Specialists Sponsoring HPA Friends & Family Golf Tournament 2
... at Boston University School of Medicine (BUSM) have reported ... a cost-effective tool for obtaining survey response. ... of Epidemiology , were based on data from the ... study of 59,000 African American women from across the ...
... an individual,s personality and their capacity to exercise or generate ... animals that choose to exercise and as with people ... of activity, says Dr Peter Biro, a senior lecturer in ... article in the journal Trends in Ecology and Evolution ...
... in sexual function that leave them feeling guilty and ... 35th Congress of the European Society for Medical Oncology ... sexuality and fertility concerns are often not adequately addressed ... Medical Centre in Adelaide said that fertility concerns among ...
... the United Nations and co-ordinator of the Secretary-General,s High-Level Task ... keynote address at the opening evening of the Third McGill ... p.m., at Centre Mont-Royal, 2200 Mansfield St. in Montreal. ... for food and nutrition security as he presents the work ...
... Illinois at Chicago are the first to use brain ... memory function in children with pediatric bipolar disorder or ... in the October issue of the Journal of ... PBD and ADHD are very severe developmental disorders ...
... Society of Nuclear Medicine (SNM) and the Society ... new North American Guidelines for Radiopharmaceutical Doses for ... protection initiative by standardizing doses (based on body ... in children. The Alliance for Radiation Safety in ...
Cached Medicine News:Health News:Personality and exercise levels may be linked 2Health News:Fertility concerns of cancer survivors inadequately addressed, study finds 2Health News:Fertility concerns of cancer survivors inadequately addressed, study finds 3Health News:Coordinator of UN high-level task force to open McGill Food Security Conference 2Health News:Brain imaging identifies differences in childhood bipolar disorder, ADHD 2Health News:SNM and Image GentlyTM launch initiative to standardize radiation dose in pediatric nuclear medicine 2Health News:SNM and Image GentlyTM launch initiative to standardize radiation dose in pediatric nuclear medicine 3
The Accuref 8001 allows you to measure much smaller pupils than conventional units and 3 step Target light adjuster ensures accurate results....
The amazingly compact refractor VISUTRON 900+ follows a simple principle: one knob is enough. It offers the user maximal ease, speed, and economics. The quick and silent change of glasses helps the ...
Sterile free isotonic balanced salt solution...
Sterile perfluorocarbon for intraocular Application....
Medicine Products: